nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Note on Population Analysis of Dissolution-Absorption Models Using the Inverse Gaussian Function
|
Jian Wang, |
|
2008 |
48 |
6 |
p. 719-725 |
artikel |
2 |
Comparative Inhibitory Activity of Etoricoxib, Celecoxib, and Diclofenac on COX-2 Versus COX-1 in Healthy Subjects
|
Schwartz, Jules I. |
|
2008 |
48 |
6 |
p. 745-754 |
artikel |
3 |
Cutaneous Pharmacodynamics of a Toll-Like Receptor 7 Agonist, 852A, in Humans
|
Astry, Calvin |
|
2008 |
48 |
6 |
p. 755-762 |
artikel |
4 |
Dose- and Time-Dependent Pharmacokinetics of Midostaurin in Patients With Diabetes Mellitus
|
Yanfeng Wang, |
|
2008 |
48 |
6 |
p. 763-775 |
artikel |
5 |
DrugInteractions/Review: New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process
|
Huang, Shiew-Mei |
|
2008 |
48 |
6 |
p. 662-670 |
artikel |
6 |
Limitations of Using a Single Postdose Midazolam Concentration to Predict CYP3A-Mediated Drug Interactions
|
Penzak, Scott R. |
|
2008 |
48 |
6 |
p. 671-680 |
artikel |
7 |
Multiple-Dose Pharmacokinetics, Pharmacodynamics, and Safety of Taranabant, a Novel Selective Cannabinoid-1 Receptor Inverse Agonist, in Healthy Male Volunteers
|
Addy, Carol |
|
2008 |
48 |
6 |
p. 734-744 |
artikel |
8 |
Population Exposure-Response Modeling of Metformin in Patients With Type 2 Diabetes Mellitus
|
Ying Hong, |
|
2008 |
48 |
6 |
p. 696-707 |
artikel |
9 |
Population Pharmacokinetic and Pharmacodynamic Analysis of Pegloticase in Subjects With Hyperuricemia and Treatment-Failure Gout
|
Corinne Seng Yue, |
|
2008 |
48 |
6 |
p. 708-718 |
artikel |
10 |
Population Pharmacokinetics of Infliximab in Patients With Ankylosing Spondylitis
|
Zhenhua Xu, |
|
2008 |
48 |
6 |
p. 681-695 |
artikel |
11 |
Raltegravir Thorough QT/QTc Study: A Single Supratherapeutic Dose of Raltegravir Does Not Prolong the QTcF Interval
|
Iwamoto, M. |
|
2008 |
48 |
6 |
p. 726-733 |
artikel |